BIRC5 (survivin): a pejorative prognostic marker in stage II/III breast cancer with no response to neoadjuvant chemotherapy by Hamy, A. S., Bieche, I., Lehmann-Che, J., Scott, V., Bertheau, Ph, Guinebretière, J. M., Matthieu, M. C., Sigal-Zafrani, B., Tembo, O., Marty, M., Asselain, B., Spyratos, F., de Cremoux, P.

Get full text